These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 8280135

  • 21. Expression of integrated hepatitis B virus X variants in human hepatocellular carcinomas and its significance.
    Chen WN, Oon CJ, Leong AL, Koh S, Teng SW.
    Biochem Biophys Res Commun; 2000 Oct 05; 276(3):885-92. PubMed ID: 11027564
    [Abstract] [Full Text] [Related]

  • 22. Characterization of the role of individual protein binding motifs within the hepatitis B virus enhancer I on X promoter activity using linker scanning mutagenesis.
    Gustin K, Shapiro M, Lee W, Burk RD.
    Virology; 1993 Apr 05; 193(2):653-60. PubMed ID: 8384750
    [Abstract] [Full Text] [Related]

  • 23. Differential integration rates of hepatitis B virus DNA in the liver of children with chronic hepatitis B virus infection and hepatocellular carcinoma.
    Huang HP, Tsuei DJ, Wang KJ, Chen YL, Ni YH, Jeng YM, Chen HL, Hsu HY, Chang MH.
    J Gastroenterol Hepatol; 2005 Aug 05; 20(8):1206-14. PubMed ID: 16048568
    [Abstract] [Full Text] [Related]

  • 24. Characterization of HBV integrants in 14 hepatocellular carcinomas: association of truncated X gene and hepatocellular carcinogenesis.
    Wang Y, Lau SH, Sham JS, Wu MC, Wang T, Guan XY.
    Oncogene; 2004 Jan 08; 23(1):142-8. PubMed ID: 14712219
    [Abstract] [Full Text] [Related]

  • 25. Biological impact of natural COOH-terminal deletions of hepatitis B virus X protein in hepatocellular carcinoma tissues.
    Tu H, Bonura C, Giannini C, Mouly H, Soussan P, Kew M, Paterlini-Bréchot P, Bréchot C, Kremsdorf D.
    Cancer Res; 2001 Nov 01; 61(21):7803-10. PubMed ID: 11691796
    [Abstract] [Full Text] [Related]

  • 26. Clonal origin of human hepatoma determined by integration of hepatitis B virus DNA.
    Esumi M, Aritaka T, Arii M, Suzuki K, Tanikawa K, Mizuo H, Mima T, Shikata T.
    Cancer Res; 1986 Nov 01; 46(11):5767-71. PubMed ID: 3019535
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Relationship between mutation on precore region of integrated HBV DNA and p53 gene mutation in hepatocellular carcinoma].
    Wang XH, Wang PL.
    Ai Zheng; 2003 Jul 01; 22(7):715-8. PubMed ID: 12866962
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Trans-activation function of a 3' truncated X gene-cell fusion product from integrated hepatitis B virus DNA in chronic hepatitis tissues.
    Takada S, Koike K.
    Proc Natl Acad Sci U S A; 1990 Aug 01; 87(15):5628-32. PubMed ID: 2165598
    [Abstract] [Full Text] [Related]

  • 31. The HBV X-ORF encodes a transactivator: a potential factor in viral hepatocarcinogenesis.
    Zahm P, Hofschneider PH, Koshy R.
    Oncogene; 1988 Aug 01; 3(2):169-77. PubMed ID: 2457861
    [Abstract] [Full Text] [Related]

  • 32. Impact of hepatitis B virus (HBV) X gene integration in liver tissue on hepatocellular carcinoma development in serologically HBV-negative chronic hepatitis C patients.
    Toyoda H, Kumada T, Kaneoka Y, Murakami Y.
    J Hepatol; 2008 Jan 01; 48(1):43-50. PubMed ID: 18023912
    [Abstract] [Full Text] [Related]

  • 33. Identification and characterization of a prevalent hepatitis B virus X protein mutant in Taiwanese patients with hepatocellular carcinoma.
    Yeh CT, Shen CH, Tai DI, Chu CM, Liaw YF.
    Oncogene; 2000 Nov 02; 19(46):5213-20. PubMed ID: 11077437
    [Abstract] [Full Text] [Related]

  • 34. A hepatocellular carcinoma cell line producing mature hepatitis B viral particles.
    Fellig Y, Almogy G, Galun E, Ketzinel-Gilad M.
    Biochem Biophys Res Commun; 2004 Aug 20; 321(2):269-74. PubMed ID: 15358171
    [Abstract] [Full Text] [Related]

  • 35. Hepatitis B virus-related insertional mutagenesis in chronic hepatitis B patients as an early drastic genetic change leading to hepatocarcinogenesis.
    Minami M, Daimon Y, Mori K, Takashima H, Nakajima T, Itoh Y, Okanoue T.
    Oncogene; 2005 Jun 23; 24(27):4340-8. PubMed ID: 15806150
    [Abstract] [Full Text] [Related]

  • 36. The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.
    Matsuzaki Y, Sato M, Saito Y, Karube M, Doy M, Shoda J, Abei M, Tanaka N, Hadama T, Kinoshita M.
    J Exp Clin Cancer Res; 1999 Sep 23; 18(3):379-89. PubMed ID: 10606185
    [Abstract] [Full Text] [Related]

  • 37. Establishment of cell lines using a doxycycline-inducible gene expression system to regulate expression of hepatitis B virus X protein.
    Tang H, Liu L, Liu FJ, Chen EQ, Murakami S, Lin Y, He F, Zhou TY, Huang FJ.
    Arch Virol; 2009 Sep 23; 154(7):1021-6. PubMed ID: 19495936
    [Abstract] [Full Text] [Related]

  • 38. Sequencing of human-viral DNA junctions in hepatocellular carcinoma from patients with HCV and occult HBV infection.
    Tamori A, Nishiguchi S, Kubo S, Enomoto M, Koh N, Takeda T, Shiomi S, Hirohashi K, Kinoshita H, Otani S.
    J Med Virol; 2003 Apr 23; 69(4):475-81. PubMed ID: 12601754
    [Abstract] [Full Text] [Related]

  • 39. [Hepatitis viruses and hepatocarcinogenesis].
    Kiss A, Lotz G, Kaposi NP, Schaff Z.
    Orv Hetil; 2002 Jan 13; 143(2):83-6. PubMed ID: 11868453
    [Abstract] [Full Text] [Related]

  • 40. Mutant p53 but not hepatitis B virus X protein is present in hepatitis B virus-related human hepatocellular carcinoma.
    Henkler F, Waseem N, Golding MH, Alison MR, Koshy R.
    Cancer Res; 1995 Dec 15; 55(24):6084-91. PubMed ID: 8521397
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.